Pages that link to "Q41075101"
Jump to navigation
Jump to search
The following pages link to Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine (Q41075101):
Displaying 50 items.
- Hydromorphone for acute and chronic pain (Q24197637) (← links)
- Opioid switching to improve pain relief and drug tolerability (Q24197642) (← links)
- Opioid switching to improve pain relief and drug tolerability (Q24246707) (← links)
- Methadone: applied pharmacology and use as adjunctive treatment in chronic pain (Q24680259) (← links)
- Strong opioids for cancer pain (Q28353103) (← links)
- Hyperalgesia and opioid switching (Q30049083) (← links)
- Pain care for patients with epidermolysis bullosa: best care practice guidelines (Q30590549) (← links)
- Opioid plasma concentration during switching from morphine to methadone: preliminary data (Q30784757) (← links)
- Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine. (Q32047672) (← links)
- An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain (Q33503399) (← links)
- Doctor Shopping Behavior and the Diversion of Prescription Opioids (Q33585329) (← links)
- Opioid rotation for cancer pain: rationale and clinical aspects (Q33765787) (← links)
- Methadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain. (Q33834448) (← links)
- Trends in Cancer Pain Management (Q33887619) (← links)
- The use of methadone for cancer pain (Q33960768) (← links)
- Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids (Q34000978) (← links)
- Management of specific symptom complexes in patients receiving palliative care (Q34028981) (← links)
- Advances in cancer pain management (Q34107982) (← links)
- Accuracy in equianalgesic dosing. conversion dilemmas (Q34258424) (← links)
- Strategies for the treatment of cancer pain in the new millennium (Q34297489) (← links)
- Opioid rotation in clinical practice (Q34305249) (← links)
- Switching from methadone to a different opioid: what is the equianalgesic dose ratio? (Q34315327) (← links)
- Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing (Q34331439) (← links)
- Toward a systematic approach to opioid rotation (Q34394425) (← links)
- The management of pain in the oncology patient (Q34477414) (← links)
- Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl (Q34519887) (← links)
- Symptom assessment and management (Q34537781) (← links)
- Hydromorphone for acute and chronic pain. (Q34546948) (← links)
- Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain (Q34552445) (← links)
- The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal (Q34580479) (← links)
- Switching from oxycodone to methadone in advanced cancer patients (Q34632120) (← links)
- Recent progress in the pharmacotherapy of cancer pain (Q34734247) (← links)
- Intravenous high-dose methadone administered by patient controlled analgesia and continuous infusion for the treatment of cancer pain refractory to high-dose morphine (Q34744072) (← links)
- Benefit-Risk Assessment of Transdermal Fentanyl for the Treatment of Chronic Pain (Q35570047) (← links)
- Clinical use of methadone (Q35598093) (← links)
- Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study (Q35752995) (← links)
- Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study (Q36088599) (← links)
- Methadone for cancer pain: what have we learned from clinical studies? (Q36135137) (← links)
- Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review (Q36141860) (← links)
- Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem. (Q36214719) (← links)
- Controversies in pharmacotherapy of pain management. (Q36243753) (← links)
- Opioid switch in palliative care, opioid choice by clinical need and opioid availability (Q36247567) (← links)
- Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS(®) hydromorphone ER) in patients with chronic pain (Q36407485) (← links)
- Methadone for treatment of cancer pain. (Q36718624) (← links)
- Opioid conversions in acute care (Q36735197) (← links)
- Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain (Q36821199) (← links)
- Management strategies for pain in breast carcinoma patients: current opinions and future perspectives (Q36845203) (← links)
- Interindividual variability of methadone response: impact of genetic polymorphism (Q37142009) (← links)
- Is oral methadone better than placebo or other oral/transdermal opioids in the management of pain? (Q37894995) (← links)
- Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review (Q37894998) (← links)